MedTrace Logo

Evaluating the Feasibility of Using M-Health to Improve Serum Glucose Logs

NCT03340311 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2018-05-01

No results posted yet for this study

Summary

Gestational diabetes mellitus (GDM) can cause adverse outcomes for the mother and fetus due to hyperglycemia. The purpose of this study is to evaluate the feasibility of improving pregnant women's glucose logs using a Bluetooth enabled glucose monitor and associated mobile health application and to assess their satisfaction with using mobile health technology.

Conditions

  • Gestational Diabetes Mellitus

Interventions

DEVICE

iHealth Wireless Smart Gluco- Monitoring System (BG5)

Over the course of 8 weeks, participants collected serum glucose logs (SGL) for 4 weeks using usual care followed by SGL's log for 4 weeks using Bluetooth-enabled glucometers and the iGluco application.

Sponsors & Collaborators

  • Leslie Balcazar De Martinez

    lead OTHER

Principal Investigators

  • Emily Drake, RN, Ph.D · University of Virginia

Study Design

Purpose
OTHER
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2018-04-28
Completion
2018-04-28
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03340311 on ClinicalTrials.gov